Pregnant women that had HBsAg testing (NQF 0608)

eMeasure Name Pregnant women that had HBsAg testing eMeasure Id DA06607A-3195-4965-8AA5-9BD6555BF17F
Version number 1 eMeasure Set Id 15ED6B01-9052-4C6F-AADD-F9C68997490A
Available Date No information Measurement Period January 1, 20xx through December 31, 20xx
Measure Steward Ingenix
Endorsed by National Quality Forum
Description This measure reports compliance to hepatitis B surface antigen (HBsAg) testing during pregnancy; if the HBsAg test is absent, then the exclusion criteria (diagnosis of hepatitis B infection) is applied.
Copyright
Measure scoring Proportion
Measure type Process
Stratification
None
Risk Adjustment
None
Data Aggregation
Rationale
The USPSTF found good evidence that universal prenatal screening for HBV infection using HBsAg substantially reduces prenatal transmission of HBV and the subsequent development of chronic HBV infection (1). The current practice of vaccinating all infants against HBV infection and postexposure prophylaxis with hepatitis B immune globulin administered at birth to infants of HBV-infected mothers substantially reduces the risk for acquiring HBV infection.
Clinical Recommendation Statement
The U.S. Preventive Services Task Force (USPSTF) strongly recommends screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit (1). This is a grade A* recommendation from the USPSTF.  In addition, the American College of Obstetricians and Gynecologists (ACOG) recommend screening all pregnant women for HBV infection (2).
Improvement notation
Higher score indicates better quality
Measurement duration
12 month(s)
Reference
U.S. Preventive Services Task Force. Screening for Hepatitis B Infection: Recommendation Statement. February 2004. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/hepbscr/hepbrs.htm Accessed June 10, 2009
Reference
American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for perinatal care, 5th ed. Elk Grove Village (IL): AAP; Washington, DC: ACOG; 2002.
Definition
Initial Patient Population(s): All female patients aged 12 and older who had a full term delivery during the measurement period
Definition
Denominator(s): All patients in the initial population
Definition
Denominator Exclusion(s): Patients with current or past Hepatitis B infection
Definition
Numerator(s): The number of patients who were tested for Hepatitis B surface antigen (HBsAg) during pregnancy
Definition
Denominator Exception(s): N/A
Guidance
Supplemental Data Elements
Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".

Table of Contents


Population criteria

Data criteria (QDM Data Elements)

Supplemental Data Elements




Measure set CLINICAL QUALITY MEASURE SET 2011-2012